• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖化控制优化对 1 型糖尿病甘露糖结合凝集素的影响。

Effect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes.

机构信息

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8000 Aarhus, Denmark.

Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.

出版信息

J Diabetes Res. 2017;2017:1249729. doi: 10.1155/2017/1249729. Epub 2017 Nov 26.

DOI:10.1155/2017/1249729
PMID:29318157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5727755/
Abstract

OBJECTIVE

Mannan-binding lectin (MBL) concentration in plasma is increased in subjects with type 1 diabetes and associated with increased mortality and risk of diabetic nephropathy. Recent findings show that pancreas transplantation reduces MBL concentration. Whether the increased MBL concentration is reversed by improved glycaemic control remains unknown. We investigated the effects of improved glycaemic control on MBL concentration in patients with type 1 diabetes.

METHODS

We measured MBL, fructosamine, and HbAat baseline and after 6 weeks in 52 type 1 diabetic patients following the change from conventional insulin therapy to insulin pump therapy.

RESULTS

After initiation of insulin pump therapy, the total daily insulin dose was significantly reduced (from 51 ± 18 IE/day to 39 ± 13 IE/day, < 0.0001). There was a significant decrease in HbA from 8.6% to 7.7% (from 70 mmol/mol to 61 mmol/mol, < 0.0001) and in fructosamine levels (from 356 mol/L to 311 mol/L, < 0.0001). MBL levels decreased by 10% from 2165 g/L (IQR 919-3389 g/L) at baseline to 1928 /L (IQR 811-2758 g/L) at follow-up ( = 0.005), but MBL change was not significantly correlated with changes in insulin dose, HbA, or fructosamine.

CONCLUSIONS

MBL concentration decreased following the initiation of insulin pump therapy in patients with type 1 diabetes and did not correlate with changes in glycaemic control.

摘要

目的

1 型糖尿病患者血浆甘露聚糖结合凝集素(MBL)浓度升高,与死亡率增加和糖尿病肾病风险增加相关。最近的研究结果表明,胰腺移植可降低 MBL 浓度。血糖控制改善是否会逆转 MBL 浓度升高尚不清楚。我们研究了血糖控制改善对 1 型糖尿病患者 MBL 浓度的影响。

方法

我们在 52 名接受常规胰岛素治疗改为胰岛素泵治疗的 1 型糖尿病患者中,测量了基线时和 6 周后的 MBL、果糖胺和 HbA1c。

结果

开始胰岛素泵治疗后,总日胰岛素剂量显著减少(从 51±18IE/天降至 39±13IE/天, <0.0001)。HbA1c 从 8.6%降至 7.7%(从 70mmol/mol 降至 61mmol/mol, <0.0001),果糖胺水平也显著降低(从 356mol/L 降至 311mol/L, <0.0001)。MBL 水平从基线时的 2165g/L(IQR 919-3389g/L)下降 10%至随访时的 1928g/L(IQR 811-2758g/L)( = 0.005),但 MBL 变化与胰岛素剂量、HbA1c 或果糖胺的变化无显著相关性。

结论

1 型糖尿病患者开始胰岛素泵治疗后 MBL 浓度降低,与血糖控制变化无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b9/5727755/35cfc5a9cd7a/JDR2017-1249729.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b9/5727755/3f98e5621a03/JDR2017-1249729.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b9/5727755/35cfc5a9cd7a/JDR2017-1249729.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b9/5727755/3f98e5621a03/JDR2017-1249729.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5b9/5727755/35cfc5a9cd7a/JDR2017-1249729.002.jpg

相似文献

1
Effect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes.糖化控制优化对 1 型糖尿病甘露糖结合凝集素的影响。
J Diabetes Res. 2017;2017:1249729. doi: 10.1155/2017/1249729. Epub 2017 Nov 26.
2
Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.使用连续血糖监测评估慢性肾脏病糖尿病患者的血糖控制标志物。
Nephrology (Carlton). 2012 Feb;17(2):182-8. doi: 10.1111/j.1440-1797.2011.01517.x.
3
Simultaneous pancreas-kidney transplantation in patients with type 1 diabetes reverses elevated MBL levels in association with MBL2 genotype and VEGF expression.1型糖尿病患者同时进行胰腺-肾脏移植可逆转与MBL2基因型和VEGF表达相关的MBL水平升高。
Diabetologia. 2016 Apr;59(4):853-8. doi: 10.1007/s00125-015-3858-3. Epub 2016 Jan 15.
4
Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.在接受铁剂或促红细胞生成素治疗的糖尿病肾病患者中,使用补充标志物评估血糖控制情况。
Diabet Med. 2013 Oct;30(10):1250-4. doi: 10.1111/dme.12249. Epub 2013 Jul 9.
5
Effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy.不同血糖生成指数食物和膳食纤维摄入量对接受强化胰岛素治疗的1型糖尿病患者血糖控制的影响。
Diabet Med. 1998 Nov;15(11):972-8. doi: 10.1002/(SICI)1096-9136(1998110)15:11<972::AID-DIA704>3.0.CO;2-2.
6
Elevated levels of mannan-binding lectin in patients with type 1 diabetes.1型糖尿病患者中甘露糖结合凝集素水平升高。
J Clin Endocrinol Metab. 2003 Oct;88(10):4857-61. doi: 10.1210/jc.2003-030742.
7
Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.在苏格兰进行的一项全国性观察研究显示,1 型糖尿病患者启用胰岛素泵治疗后血糖控制明显改善。
Diabetologia. 2021 Jun;64(6):1320-1331. doi: 10.1007/s00125-021-05413-7. Epub 2021 Mar 8.
8
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy.1型糖尿病早期和显性肾病患者中甘露糖结合凝集素水平升高。
Diabetologia. 2005 Jan;48(1):198-202. doi: 10.1007/s00125-004-1594-1. Epub 2004 Dec 23.
9
The predictive value of serum mannan-binding lectin levels for diabetic control and renal complications in type 2 diabetic patients.血清甘露聚糖结合凝集素水平对2型糖尿病患者血糖控制及肾脏并发症的预测价值。
Saudi Med J. 2011 Aug;32(8):784-90.
10
Insulin pump-long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden.胰岛素泵-对血糖控制的长期影响:瑞典 10 家糖尿病诊所的观察性研究。
Diabetes Technol Ther. 2013 Apr;15(4):302-7. doi: 10.1089/dia.2012.0286. Epub 2013 Mar 28.

引用本文的文献

1
Applications of mannose-binding lectins and mannan glycoconjugates in nanomedicine.甘露糖结合凝集素和甘露聚糖糖缀合物在纳米医学中的应用。
J Nanopart Res. 2022;24(11):228. doi: 10.1007/s11051-022-05594-1. Epub 2022 Nov 4.

本文引用的文献

1
Simultaneous pancreas-kidney transplantation in patients with type 1 diabetes reverses elevated MBL levels in association with MBL2 genotype and VEGF expression.1型糖尿病患者同时进行胰腺-肾脏移植可逆转与MBL2基因型和VEGF表达相关的MBL水平升高。
Diabetologia. 2016 Apr;59(4):853-8. doi: 10.1007/s00125-015-3858-3. Epub 2016 Jan 15.
2
Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study.1 型糖尿病伴甘露聚糖结合凝集素高表达基因型患者全因死亡率增加:一项 12 年随访研究。
Diabetes Care. 2015 Oct;38(10):1898-903. doi: 10.2337/dc15-0851. Epub 2015 Jul 15.
3
Diabetes-induced changes in mannan-binding lectin levels and complement activation in a mouse model of type 1 diabetes.
1 型糖尿病小鼠模型中甘露聚糖结合凝集素水平和补体激活的糖尿病诱导变化。
Scand J Immunol. 2013 Mar;77(3):187-94. doi: 10.1111/sji.12027.
4
Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.靶向甘露糖结合凝集素可提供持久的保护,且治疗窗极宽,可用于脑缺血。
Circulation. 2012 Sep 18;126(12):1484-94. doi: 10.1161/CIRCULATIONAHA.112.103051. Epub 2012 Aug 9.
5
Mannose-binding lectin deficiency is associated with myocardial infarction: the HUNT2 study in Norway.甘露糖结合凝集素缺陷与心肌梗死有关:挪威 HUNT2 研究。
PLoS One. 2012;7(7):e42113. doi: 10.1371/journal.pone.0042113. Epub 2012 Jul 27.
6
Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages.天然免疫蛋白C1q和甘露聚糖结合凝集素可增强人单核细胞和巨噬细胞对致动脉粥样硬化脂蛋白的清除。
J Immunol. 2010 Oct 1;185(7):3932-9. doi: 10.4049/jimmunol.1002080. Epub 2010 Sep 10.
7
Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes.甘露糖结合凝集素、高敏 C 反应蛋白与 1 型糖尿病患者糖尿病肾病进展的关系。
Diabetologia. 2010 Jul;53(7):1517-24. doi: 10.1007/s00125-010-1742-8. Epub 2010 Apr 16.
8
Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.甘露糖结合凝集素在巨噬细胞中的特异性表达可控制低密度脂蛋白受体缺陷小鼠的动脉粥样硬化。
Circulation. 2009 Apr 28;119(16):2188-95. doi: 10.1161/CIRCULATIONAHA.108.830661. Epub 2009 Apr 20.
9
Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy.MBL浓度升高并不表明MBL2基因与1型糖尿病或糖尿病肾病之间存在关联。
Diabetes. 2009 Jul;58(7):1710-4. doi: 10.2337/db08-1495. Epub 2009 Apr 14.
10
Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise.甘露聚糖结合凝集素(MBL)及MBL相关丝氨酸蛋白酶-2循环水平的生物学变异以及年龄、性别和体育锻炼的影响
Scand J Immunol. 2007 Oct;66(4):458-64. doi: 10.1111/j.1365-3083.2007.01991.x.